| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/30/2006 | CN1824245A Quality control method of bone sinew medicinal pill preparation |
| 08/30/2006 | CN1824239A Quality control method of kidney beneficial bone fortifying capsule |
| 08/30/2006 | CN1824204A Medicinal composition for treating acute urarthritis and its preparation method |
| 08/30/2006 | CN1824199A Medicine for treating spur and its new preparation method |
| 08/30/2006 | CN1824161A Compound joint convalscence medicine |
| 08/30/2006 | CN1824130A Medicien capable of preventing and treating cardiopathy, osteopathia, high blool pressure, diabetes etc. multi kind disease |
| 08/30/2006 | CN1824109A Liaoyuanqili medicinal preparation and its new preparation method |
| 08/30/2006 | CN1824108A Medicine for blood stanching, stasis transforming and bone joining |
| 08/30/2006 | CN1824103A External use medicine for treating knocks and falls and bone joining |
| 08/30/2006 | CN1824009A Multipurpose medicinal composition capable of oral administration and external use |
| 08/30/2006 | CN1823983A Medicine for treatign osteopathia, rheumatism and immune disease and its preparation method and use |
| 08/30/2006 | CN1823972A Medicine for treating celevical vertebra disease |
| 08/30/2006 | CN1823963A Medicine for treating dampness damage and preparation method |
| 08/30/2006 | CN1823951A Medicinal formula for treating omitis |
| 08/30/2006 | CN1823935A Preparation medicine of wind dispelling pain eliminating tablet and its preparation methid, quality control method |
| 08/30/2006 | CN1823931A Chinese medicine Hulisan for treating wind damp and knocks and falls |
| 08/30/2006 | CN1823930A Chinese medicinal tablet for sootbing channels and quickening network vessels and its preparing process |
| 08/30/2006 | CN1823928A Medicinal formula for treating cervical vertebra disease |
| 08/30/2006 | CN1823924A Fangji joint preparation and its preparation method |
| 08/30/2006 | CN1823910A Joint pain preparation and its new preparation method |
| 08/30/2006 | CN1823907A Humuli scandentis herbal wine for treating omarthritis |
| 08/30/2006 | CN1823879A New use of mimosae pudicae herba medicine for treating spine nerve disease |
| 08/30/2006 | CN1823878A Capsule for preventing and treating bone disease |
| 08/30/2006 | CN1823870A Celastrus orbiculatus ready prepared Chinese medicine and its application in resisting rheumatoid disease |
| 08/30/2006 | CN1823865A Chinese medicinal extract for treating osteosis and its preparation |
| 08/30/2006 | CN1823764A Medicinal composition containing strontium fuminate and vitamin D |
| 08/30/2006 | CN1823758A Compounds and methods of treating transplant rejection |
| 08/30/2006 | CN1823711A Cosmetic compositions and methods of use |
| 08/30/2006 | CN1823704A Cleaning composition |
| 08/30/2006 | CN1272331C Method of extracting three effective components in kudzu vine root |
| 08/30/2006 | CN1272326C Phenylpyridazine derivatives and drugs containing the same |
| 08/30/2006 | CN1272058C Pathogenic wind dispelling powder for treating arthritis |
| 08/30/2006 | CN1272051C Chinese traditional medicine for curing synovitis and preparation method |
| 08/30/2006 | CN1272050C Hyperosteogeny plaster |
| 08/30/2006 | CN1272030C Chinese traditional medicine for treating pain of neck, shoulder, waist and leg and preparation method thereof |
| 08/30/2006 | CN1272029C Externally applied Chinese medicine for treating spur and hyperosteogeny |
| 08/30/2006 | CN1272022C Composition for treatment of articular cartilage damage |
| 08/30/2006 | CN1272020C Composition of hypochlorous acid and its applications |
| 08/30/2006 | CN1272014C Enteric soluble preparation of Alun phosphorate and its preparing method |
| 08/30/2006 | CN1272013C Use of bisphosphonates in preparing drugs for treating diseases with abnormal bone formation in bone remodeling |
| 08/30/2006 | CN1272002C Supermolecular intercalation-structure slow-release captopril and its preparing method |
| 08/30/2006 | CN1272000C Troxerutin-coumarin dripping pill |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098322 Tumor necrosis factor and proteins with amino acid sequences to modulate signal passageways |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098223 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 08/29/2006 | US7098216 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/29/2006 | US7098213 three-ring saturated N-heterocyclic compounds in combination with one or more antiviral or other agents; in immunotherapy |
| 08/29/2006 | US7098209 Phosphodiesterase inhibitors; cardiovascular disorders; erectile dysfunction; hypotensive agents; respiratory system diosrders; chronic obstructive pulmonary disease; congestive heart failure; antihistamines; antiallergens |
| 08/29/2006 | US7098197 An antiviral nucleoside in which the 5'-hydroxyl group has been substituted for a phosphonate or methyl phosphonate that is covalently linked to an alkylethanediol; osteoporosis; anticarcinogenic agents; viricides |
| 08/29/2006 | US7098184 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 08/29/2006 | US7097986 For use in pharmaceutical and diagnostic formulations |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097860 Administering solution containing magnesium, or compound thereof |
| 08/29/2006 | US7097834 Osteoprotegerin binding proteins |
| 08/29/2006 | CA2521980C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/29/2006 | CA2521958C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-pheyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/29/2006 | CA2402020C Pharmaceutical compositions |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088198A1 Method of producing protein by using hamster igf-1 |
| 08/24/2006 | WO2006088088A1 Pain remedy containing rock inhibitor |
| 08/24/2006 | WO2006087997A1 1-SUBSTITUTED-7-(β-D-GLYCOPYRANOSYLOXY)(AZA)INDOLE COMPOUND AND PHARMACEUTICAL CONTAINING THE SAME |
| 08/24/2006 | WO2006087077A2 Hsp90-inhibiting triazole derivatives |
| 08/24/2006 | WO2006076673A3 Use of il-i antagonists to treat polymyalgia rheumatica and giant cell arteritis |
| 08/24/2006 | WO2006018723A3 Androgen modulators |
| 08/24/2006 | WO2005116002B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/24/2006 | US20060191024 Method for preparing anti-MIF antibodies |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 08/24/2006 | US20060189650 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 08/24/2006 | US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof |
| 08/24/2006 | US20060189637 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
| 08/24/2006 | US20060189632 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine |
| 08/24/2006 | US20060189621 Benzofuran derivative |
| 08/24/2006 | US20060189598 substituted azole acid derivatives which modulate blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid levels; hypolipidemic agent; hyperglycemia, hyperinsulinemia, hyperlipidemia, obesity, atherosclerosis; Type 2 diabetes |
| 08/24/2006 | US20060189576 Substituted vitamin d analogues and their therapeutic uses |
| 08/24/2006 | US20060189567 Compound having affinity with calcified tissue |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | US20060189525 DADD, death activator death domain protein |
| 08/24/2006 | US20060188501 Diagnostic and therapeutic agents for rheumatoid arthritis |
| 08/24/2006 | CA2598570A1 Methods for producing proteins using hamster igf-1 |
| 08/24/2006 | CA2598017A1 Triazole derivatives |
| 08/24/2006 | CA2597269A1 1-substituted-7-(beta-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 08/23/2006 | EP1693367A1 Piperidine compound and method for producing same |
| 08/23/2006 | EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis |
| 08/23/2006 | EP1692275A2 Method and system for preparing stem cells from fat tissue |
| 08/23/2006 | EP1692267A2 Methods of organ regeneration |
| 08/23/2006 | EP1691814A2 Anti-inflammatory agents |
| 08/23/2006 | EP1691807A1 Indole derivatives for the treatment of bone diseases |
| 08/23/2006 | EP1485391B1 Phosphate transport inhibitors |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1339294B1 Nutritional composition for an immune condition |
| 08/23/2006 | EP1332144B1 Indole derivatives as pde5-inhibitors |
| 08/23/2006 | EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 08/23/2006 | EP1272457B1 Compounds for modulating cell proliferation |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1146870B1 Antioxidant compositions for companion animals |
| 08/23/2006 | EP1027328B1 Substituted anilides |